Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Clean Technology
Information Technology
Medical Device


CEO: Sean Mackay

Description: IsoPlexis has a proprietary single cell multiplexing immunoassay and software suite that provides in-depth biological characterization of important immune and cancer cell subsets among heterogeneous populations. The tool enables discovery of novel biomarkers and accurate testing of molecules for clinical activity against these heterogeneous subsets.


CI Representative:
Daniel Wagner
Managing Director, Investments